“Utilizing real-world data, technology, strategic solutions, and cross-departmental partnerships will help ensure equitable access, so the right member receives the right drug at the right time and ...
Medpage Today on MSN
Novel Biologic for Sjogren's Clears Penultimate Hurdle
The drug, dubbed ianalumab, both depletes B cells and deactivates those remaining, Thomas Grader-Beck, MD, of Johns Hopkins ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback